Anxiety disorders are the most common mental health conditions in the United States, yet a substantial portion of patients do not achieve adequate relief from first-line treatments like SSRIs and therapy alone (American Psychiatric Association). For those patients, the question of whether ketamine might help is not hypothetical — it is practical and urgent. At Revitalize Ketamine Clinic in Flagstaff, we work with patients across Northern Arizona who have been asking this exact question, and the honest answer is that the evidence is meaningful, though the picture is more nuanced than a simple yes or no.
Why Anxiety Is More Than Nervousness
Anxiety disorders — including generalized anxiety disorder, social anxiety disorder, and panic disorder — are characterized by persistent, excessive worry or fear that interferes with daily functioning (Mayo Clinic). That distinction between normal worry and clinical anxiety matters because it shapes what treatment is required. A stressful week does not respond to the same interventions as a chronic anxiety disorder that has persisted for years and resisted multiple medication trials.
Part of what makes treatment-resistant anxiety so difficult is its neurobiological overlap with depression. Research confirms a strong bidirectional relationship between anxiety and depression — each condition worsens the other, and both frequently involve dysregulation in overlapping neural circuits (American Journal of Psychiatry). This co-occurrence is not incidental. It means that patients who have not responded to antidepressants for depression often experience unresolved anxiety at the same time, and that the mechanisms driving both conditions may require a treatment that reaches beyond the serotonin system. If you’re navigating this overlap, our post on can depression cause emotional paralysis explores how these conditions can compound one another.
What Ketamine Does in the Brain
Most conventional treatments for anxiety target serotonin or GABA receptors. Ketamine takes a different route. It works primarily by blocking NMDA receptors — proteins in the brain that regulate glutamate, the brain’s primary excitatory neurotransmitter (National Institutes of Health). This NMDA receptor blockade triggers a cascade of downstream effects, including rapid increases in synaptic connectivity and the release of brain-derived neurotrophic factor (BDNF), a protein that supports neuron growth and communication.
This mechanism is significant for anxiety patients specifically because the glutamate system plays a central role in the fear and threat-processing circuits that become dysregulated in anxiety disorders. By modulating glutamate transmission rather than serotonin, ketamine reaches a part of the neurobiology that SSRIs and SNRIs do not directly address. That is not a marketing claim — it is the neurobiological rationale that has driven over a decade of research at institutions including the NIH, Yale, Harvard, and Johns Hopkins. For a deeper look at how this process works, see our overview of the science behind ketamine therapy.
What the Research Shows
Clinical evidence supports ketamine’s effectiveness in rapidly reducing anxiety symptoms, offering relief for patients with anxiety disorders that have not responded to standard treatments (National Institutes of Health). The speed of response is one of the most clinically notable features — many patients report meaningful symptom reduction within hours to days of an infusion, compared to the weeks required by traditional antidepressants to reach therapeutic effect.
The bidirectional relationship between anxiety and depression also matters for interpreting ketamine’s effects in this population. Research shows that treating one condition often produces measurable improvement in the other (American Journal of Psychiatry). For patients who present with both anxiety and depression — which is common — ketamine’s mechanism may address both simultaneously rather than requiring separate treatment tracks. Our guide to ketamine for anxiety relief goes into further detail on what this looks like in a clinical setting.
It is worth being precise about what this research does and does not show. Most of the clinical literature on ketamine focuses on treatment-resistant depression and PTSD, with anxiety relief often observed as a co-occurring benefit. The evidence specifically for anxiety disorders as a primary diagnosis is growing and promising, but it is not as large a body of literature as the depression evidence base. We are direct about this with every patient we see for anxiety at Revitalize, because informed decision-making requires an accurate picture of where the science currently stands.
How We Approach Anxiety Treatment at Revitalize
When a patient comes to us with anxiety as a primary concern, we start with a comprehensive evaluation — not a quick intake form. Our team reviews your full psychiatric history, your medication trials, and how you have responded to prior treatments. Jill Dubravcic, our medical director and a Psychiatric Mental Health Nurse Practitioner, is knowledgeable across all psychiatric conditions including anxiety, panic attacks, and PTSD. Casey Dubravcic, our co-founder and PMHNP, brings years of experience evaluating patients for whom standard treatments have not been enough.
We also discuss the role of integration. Research on ketamine-assisted psychotherapy suggests that pairing infusions with psychological support may produce more durable outcomes than ketamine alone (National Institutes of Health). Cilla Pennington, our licensed integration therapist, works with patients to process what emerges during and after treatment — a step that is particularly relevant for anxiety patients, whose nervous systems are often primed for hypervigilance even after symptoms begin to lift. Integration is not mandatory, but we make it available because we believe it is clinically meaningful.
For patients who qualify, we also offer at-home ketamine therapy via sublingual troches as a maintenance option following an initial in-clinic series. This can be a practical consideration for anxiety patients who find repeated clinic visits activating — there is something to be said for being able to continue treatment in a familiar, controlled home environment with local support available if needed.
What to Expect If You Are Considering Ketamine for Anxiety
A standard IV ketamine induction series at Revitalize involves six infusions administered over an initial course. Each session is approximately 90 minutes, during which you are awake but in a dissociative, relaxed state. Your vitals are monitored throughout. You will need a driver home after each session. The intake and first session costs $625 and includes a physical assessment, comprehensive evaluation, and integration workbook review. Infusions two through six are $525 each. Maintenance sessions after an induction series are $425 each.
Insurance does not currently cover IV ketamine for anxiety. We are transparent about this. If cost is a barrier, we encourage you to ask about your specific situation during a consultation — and to also explore TMS, which is covered by Cigna, Evernorth, Tricare West, Aetna, and Blue Cross Blue Shield for patients who meet clinical criteria. TMS therapy in Flagstaff is FDA-approved for depression and anxiety and uses magnetic pulses rather than medication to stimulate brain circuits involved in mood and threat regulation. It is a meaningful alternative for patients who are hesitant about infusions or for whom cost is a significant factor.
Frequently Asked Questions
Is ketamine FDA-approved for anxiety? Ketamine is not FDA-approved specifically for anxiety disorders. Its use for anxiety is considered off-label — meaning it is prescribed outside its FDA-approved anesthetic indication based on a growing body of clinical evidence. Off-label prescribing is common and legal; an estimated quarter of all prescriptions in the United States are written off-label. We discuss this clearly with every patient before treatment begins.
How quickly might I notice a difference? Many patients report meaningful anxiety reduction within hours to days of an infusion — a timeline that is much faster than conventional antidepressants. That said, individual response varies. Some patients notice changes after the first or second infusion; others respond more gradually across the series. We monitor your progress throughout and adjust our approach accordingly. Results vary by individual.
Can ketamine make anxiety worse? During the infusion, some patients experience a temporary dissociative state that can feel disorienting, particularly for those with high baseline anxiety. This is normal and typically resolves quickly after the session ends. Our team is present and monitoring throughout, and if you find the experience activating, we can adjust dosing. We discuss this risk honestly during your initial consultation so you can make an informed decision about whether to proceed.
Should I stop my current anxiety medication before starting ketamine? Not without guidance from your prescribing provider. Some medications interact with ketamine and may reduce its effectiveness or affect safety. We review your full medication list during intake and will work with your existing providers to coordinate your care. We do not ask patients to abruptly discontinue medications — changes, if warranted, are made gradually and with medical supervision.
What if ketamine does not help my anxiety? Not everyone responds to ketamine, and we will not know how you will respond until we try. If IV ketamine does not produce meaningful relief, that is information — and we will use it to discuss what other evidence-based options may be appropriate for your situation, including TMS or medication management with a focus on optimizing or deprescribing your current regimen. We do not view a non-response as the end of the road. Discuss your options with your provider at every stage of treatment.
Key Takeaways
- Clinical evidence supports ketamine’s ability to rapidly reduce anxiety symptoms, particularly for patients who have not responded to standard treatments like SSRIs.
- Ketamine works through the glutamate system via NMDA receptor blockade — a different mechanism than conventional anxiety medications, which is why it may help when other treatments have not.
- Anxiety and depression frequently co-occur and share neurobiological pathways; ketamine’s mechanism may address both conditions simultaneously.
- IV ketamine is not FDA-approved specifically for anxiety and is used off-label for this indication; TMS is FDA-approved for anxiety and carries insurance coverage through major carriers.
- Results vary by individual; a thorough intake evaluation, medical supervision, and integration support are all part of how we approach anxiety treatment at Revitalize.
If you have been living with anxiety that has not responded to standard treatment and you want to understand whether ketamine or TMS might be appropriate for your situation, we are ready to have that conversation. Call Revitalize Ketamine Clinic at 928-589-0567 or schedule a consultation online. We serve patients in Flagstaff, Sedona, and Prescott Valley, and we will give you an honest assessment of your options.
References
Ketamine for Anxiety. National Institutes of Health. https://pubmed.ncbi.nlm.nih.gov/31339086/
Link Between Anxiety and Depression. American Journal of Psychiatry. https://psychiatryonline.org/doi/10.1176/appi.ajp.2020.20030305
NMDA Receptor / Glutamate System. National Institutes of Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC5148235/
Ketamine-Assisted Psychotherapy. National Institutes of Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC9207256/
Symptoms of Anxiety. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/anxiety/symptoms-causes/syc-20350961
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy and TMS should only be pursued under the supervision of a licensed provider familiar with your full medical and psychiatric history. Individual results vary. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.